Chronic Liver Disease Patterns Differ by Ethnicity Chronic Liver Disease Patterns Differ by Ethnicity
The patterns of chronic liver disease (CLD) and cirrhosis and their underlying causes differ by ethnicity, according to results from the Multiethnic Cohort (MEC). Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 29, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

PBC can present asymptomatically in elderly patients
An 83-year-old woman who was admitted to an emergency department for unsteadiness and dizziness was eventually diagnosed with primary biliary cirrhosis (PBC), according to a case report by Patrice... (Source: Family Practice News)
Source: Family Practice News - July 28, 2016 Category: Primary Care Source Type: news

Focusing on patients and progress on World Hepatitis Day
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World Hepatitis Day brings awareness to the five hepatitis viruses that cause inflammation of the liver. This year ’s theme for the global campaign is “Elimination.” With hepatitis being the leading cause of cirrhosis and liver cancer, the disease is the most common reason for a liver transplant in the United States, according to the Centers for Disease Control and Prevention . (Source: The Catalyst)
Source: The Catalyst - July 28, 2016 Category: Pharmaceuticals Tags: chronic disease Hepatitis C Advances in Science infectious diseases Source Type: news

Focusing on patients and progress on World Hepatitis Day
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World Hepatitis Day brings awareness to the five hepatitis viruses that cause inflammation of the liver. This year ’s theme for the global campaign is “Elimination.” With hepatitis being the leading cause of cirrhosis and liver cancer, the disease is the most common reason for a liver transplant in the United States, according to the Centers for Disease Control and Prevention . (Source: The Catalyst)
Source: The Catalyst - July 28, 2016 Category: Pharmaceuticals Tags: chronic disease Hepatitis C Advances in Science infectious diseases Source Type: news

' Screen-and-treat' scheme for hepatitis B may prevent deadly complications
Research into Africa ’s first ‘screen-and-treat’ program for hepatitis B suggests the initiative may reduce deadly complications of the virus. The hepatitis B virus infects around 250 million people worldwide, and is transmitted through blood and bodily fluids. It is commonly transferred from mother to baby during birth. However the virus causes no immediate symptoms, and can remain silent in the body for decades until triggering severe complications such as liver damage (cirrhosis) and cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 27, 2016 Category: Science Source Type: news

CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
NORTH CHICAGO, Ill., July 25, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has... Biopharmaceuticals, RegulatoryAbbVie, hepatitis C, VIEKIRAX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 25, 2016 Category: Pharmaceuticals Source Type: news

Fighting life-threatening bacteria without antibiotics
Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist have now discovered that type I IFN released by immune cells due to increased migration of gut bacteria into the cirrhotic liver incapacitate the immune system. Based on their findings, such infections can be contained by strengthening the immune response -- without antibiotics. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 19, 2016 Category: Science Source Type: news

Fighting life-threatening bacteria without antibiotics
(University of Bonn) Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist at the University of Bonn and TU Munich have now discovered that type I IFN released by immune cells due to increased migration of gut bacteria into the cirrhotic liver incapacitate the immune system. Based on their findings, such infections can be contained by strengthening the immune response -- without antibiotics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2016 Category: Infectious Diseases Source Type: news

Liver diseases exhibit differing patterns in ethnic minorities
(Wiley) Chronic liver disease (CLD) and cirrhosis are serious liver conditions but little is known about how they affect ethnic minority populations in the United States. When researchers examined CLD and cirrhosis among different groups, they found that the prevalence of CLD ranged from 3.9 percent in African-Americans and Native Hawaiians to 4.1 percent in whites, 6.7 percent in Latinos, and 6.9 percent in Japanese. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2016 Category: Global & Universal Source Type: news

Carvedilol Delays Progression of Small Esophageal VaricesCarvedilol Delays Progression of Small Esophageal Varices
Treatment with carvedilol helps delay progression of small esophageal varices in patients with cirrhosis, suggest a trial conducted in India. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Early sustained viral response linked to better outcomes among HCV patients
Among patients with hepatitis C virus infection who were in compensated cirrhosis, sustained viral response was associated with significantly lower rates of liver decompensation, hepatocellular... (Source: Family Practice News)
Source: Family Practice News - July 1, 2016 Category: Primary Care Source Type: news

Poor outcome for PBC patient with bullous pemphigoid
A 45-year-old woman who was admitted with concurrent primary biliary cirrhosis or cholangitis (PBC) and bullous pemphigoid died 5 days after admittance, according to a case report from N.B. Guerra-Uribe, MD, and M.S. González-Huezo, MD. The patient was admitted to the emergency department for... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 29, 2016 Category: Dermatology Source Type: news

FDA Approves Epclusa (sofosbuvir and velpatasvir) for Treatment of all Major Forms of Chronic Hepatitis C Virus Infection
June 28, 2016 -- The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 28, 2016 Category: Drugs & Pharmacology Source Type: news

FDA approves Epclusa for treatment of chronic Hepatitis C virus infection
The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin. Epclusa is a fixed-dose combination tablet containing sofosbuvir, a drug approved in 2013, and velpatasvir, a new drug, and is the first to treat all six major forms of HCV. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 28, 2016 Category: American Health Source Type: news

The Direct-acting Antiviral Era in HCV CirrhosisThe Direct-acting Antiviral Era in HCV Cirrhosis
Despite effective treatment options for persons with HCV cirrhosis, several challenges remain including hard-to-cure groups and direct-acting anti-viral failures, and managing drug-drug interactions. Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 24, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis
 In patients with chronic hepatitis B virus infection who have been newly diagnosed with cirrhosis, the risk of hepatocellular carcinoma development can be ascertained using several clinical and molecular factors, study findings indicate. (Source: MedWire News)
Source: MedWire News - June 22, 2016 Category: Consumer Health News Tags: HBV Source Type: news

Surveillance for Liver Cancer in Hepatitis C PatientsSurveillance for Liver Cancer in Hepatitis C Patients
Can liver cancer be accurately predicted in hepatitis C patients after treatment-related cirrhosis regression, and how closely should these patients be monitored? Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 21, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Association between road accidents and low-grade hepatic encephalopathy among Sri Lankan drivers with cirrhosis: a prospective case control study - Subasinghe SK, Nandamuni Y, Ranasinghe S, Niriella MA, Miththinda JK, Dassanayake A, de Silva AP, De Silva HJ.
BACKGROUND: Low-grade hepatic encephalopathy (LGHE) comprises minimal hepatic encephalopathy (MHE) and grade 1 hepatic encephalopathy. LGHE has no or minimal recognizable symptoms but has mild cognitive and psychomotor deficits. Studies in Western countrie... (Source: SafetyLit)
Source: SafetyLit - June 20, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Hepatitis C: Once the viral infection has healed, high-risk portal vein hypertension also diminishes
This inflammatory viral infection of the liver causes inflexible scar tissue to form. This in turn impedes blood flow through the organ, with resulting hypertension in the portal vein. Portal hypertension is responsible for most of the lethal complications of liver cirrhosis. A research group has now demonstrated that portal vein hypertension also diminishes once the viral infection is healed. This is a relief for patients, because it means they can stop taking drugs with unpleasant side-effects and they do not need to undergo stressful check-ups quite as frequently. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 15, 2016 Category: Science Source Type: news

Treating Chronic HCV Infection in Decompensated CirrhosisTreating Chronic HCV Infection in Decompensated Cirrhosis
Are clinicians in agreement regarding the optimal time to begin treatment for chronic hepatitis C in patients with decompensated cirrhosis? Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 10, 2016 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

'Friendly' virus repairs damaged liver cells (but only in mice)
Conclusion This study showed it was possible to engineer and inject instructions that transform myofibroblasts into liver cells in mice with liver disease, which is quite a feat. Not all delivery mechanisms, called vectors, worked, but in those that did, the new liver cells looked normal, replaced some of the dying cells, and led to less damage due to collagen build up. Despite the alcoholism-related headline, the mice did not have alcohol-induced liver damage – although this is a major cause of liver damage in people. This study serves to prove this approach is feasible, and was successful in doing this. Researcher...
Source: NHS News Feed - June 3, 2016 Category: Consumer Health News Tags: Genetics/stem cells Lifestyle/exercise Medical practice Source Type: news

Cirrhosis-causing cells in mice turned to healthy liver cells in study
Stephen FellerSAN FRANCISCO, June 2 (UPI) -- Researchers motivated cirrhosis-causing cells in mice to become healthy liver cells, suggesting a potential treatment for liver disease other than transplant. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 2, 2016 Category: Consumer Health News Source Type: news

GPs to get help to boost early detection of liver disease
Liver disease will be clinical priority for next two years for RCGPRelated items from OnMedicaDrinking coffee reduces risk of death from liver cirrhosisMonitor people with cirrhosis for liver cancerGPs urged to boost Hep C knowledgeGPs need more training to avoid missing liver diseaseWelsh government launches plan to tackle surge in liver disease (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 2, 2016 Category: UK Health Source Type: news

Answer revealed to this top-missed USMLE Step 2 question
Getting ready for the United States Medical Licensing Examination® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert video explanation of the answer from Kaplan Medical. Once you’ve got this question under your belt, be sure to test your knowledge with other posts in this series. Ready. Set. Go. This month’s question that stumped most students:...
Source: AMA Wire - May 25, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

Treatment of Chronic Hepatitis C in Patients With CirrhosisTreatment of Chronic Hepatitis C in Patients With Cirrhosis
What is the safest and most effective way to treat patients with chronic hepatitis C with cirrhosis? Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Driving performance among patients with cirrhosis who drove to their outpatient hepatology clinic appointments - Thuluvath PJ, Nuthalapati A, Price J, Maheshwari A.
BACKGROUND: Minimal hepatic encephalopathy (MHE) may adversely affect driving skills. AIMS: To compare the driving performance of cirrhotic patients with and without prior HE as well as controls using a driving stimulator and to correlate psychometric test... (Source: SafetyLit)
Source: SafetyLit - May 21, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Tobira reports positive results from Phase l study of cenicriviroc to treat liver cirrhosis
Biopharmaceutical company Tobira Therapeutics has reported positive results from a Phase l study of cenicriviroc (CVC) in patients with liver cirrhosis and mild (Child-Pugh A) or moderate (Child-Pugh B) hepatic impairment. (Source: Drug Development Technology)
Source: Drug Development Technology - May 17, 2016 Category: Pharmaceuticals Source Type: news

Hepatocellular carcinoma risk quantified in PBC patients
Biochemical nonresponse was the most significant predictor of future risk for developing hepatocellular carcinoma among an international cohort of patients with primary biliary cirrhosis (PBC). In a... (Source: Family Practice News)
Source: Family Practice News - May 16, 2016 Category: Primary Care Source Type: news

Antiviral therapies give hepatitis C cirrhosis patients similar life expectancy as general population
The survival rate of patients with hepatitis C virus-related cirrhosis who respond well to antiviral therapies equals that of the general population, say investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 4, 2016 Category: Science Source Type: news

Cirrhosis 30-day readmissions down 40% with quality improvement initiative
Using checklists and electronic decision support in an inpatient liver unit, quality improvement (QI) care protocols reduced 30-day readmissions of patients with cirrhosis by 40%, due mostly to a... (Source: Family Practice News)
Source: Family Practice News - May 1, 2016 Category: Primary Care Source Type: news

AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
95 percent of patients achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with and without RBV in GT1 chronic HCV infected patients without cirrhosis who failed previous therapy with DAAs in a modified intent-to-treat analysis 91 percent achieved SVR12... BiopharmaceuticalsAbbVie, hepatitis C, MAGELLAN-1, ABT-493, ABT-530 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2016 Category: Pharmaceuticals Source Type: news

Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
A new study demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of hepatitis B (HBV) prolongs overall survival and reduces the risk of the most common form of liver cancer (Hepatocellular Carcinoma, HCC) and scarring of the liver (cirrhosis). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 15, 2016 Category: Science Source Type: news

Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
(European Association for the Study of the Liver) A new study, presented today at The International Liver Congress™ 2016 in Barcelona Spain, demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of hepatitis B (HBV) prolongs overall survival and reduces the risk of the most common form of liver cancer (Hepatocellular Carcinoma, HCC) and scarring of the liver (cirrhosis). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 15, 2016 Category: Infectious Diseases Source Type: news

Genetics Home Reference: cryptogenic cirrhosis
https://ghr.nlm.nih.gov/condition/cryptogenic-cirrhosis (Source: NLM General Announcements)
Source: NLM General Announcements - April 12, 2016 Category: Databases & Libraries Source Type: news

Beer has a surprisingly positive effect on reducing bone damage and women's chances for getting osteoporosis
(NaturalNews) There are plenty of reasons not to drink alcohol, we're told, but what if there were some good reasons to grab a beer from time to time?While consuming too much alcohol over a long period of time can exacerbate cirrhosis of the liver, having a cold brew occasionally... (Source: NaturalNews.com)
Source: NaturalNews.com - April 11, 2016 Category: Consumer Health News Source Type: news

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva (obeticholic acid) for the Treatment of Primary Biliary Cirrhosis
NEW YORK, April 07, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 11, 2016 Category: Drugs & Pharmacology Source Type: news

‘We have a chance to show the truth’: into the heart of Chernobyl
Three decades after the nuclear disaster, the concrete protecting the reactor is starting to crack. Yet people still live there – and a new virtual reality project will take many more inside the ‘death zone’At first they thought it was just a fire, then the chickens started to turn black. When it comes to the Chernobyl nuclear disaster, everyone has a vivid detail that is snagged in the memory; the absurdities or the obscenities. It might be the local village that, once evacuated, was claimed by a mob of pigs. Or the way milk would turn to white powder whenever the residents of Pripyat (the town built a f...
Source: Guardian Unlimited Science - April 9, 2016 Category: Science Authors: Simon Parkin Tags: Chernobyl nuclear disaster Nuclear power Virtual reality Technology Ukraine Europe World news Russia Energy Cancer Health Environment Society Source Type: news

Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial - Román E, García-Galcerán C, Torrades T, Herrera S, Marín A, Doñate M, Alvarado-Tapias E, Malouf J, Nácher L, Serra-Grima R, Guarner C, Córdoba J, Soriano G.
UNLABELLED: Patients with cirrhosis often have functional limitations, decreased muscle mass, and a high risk of falls. These variables could improve with exercise. The aim was to study the effects of moderate exercise on functional capacity, body composit... (Source: SafetyLit)
Source: SafetyLit - April 2, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

New test can predict death in patients with serious liver disease
The biomarker CD163 can predict mortality in blood samples from patients with acute on chronic liver failure, report scientists. Acute-on-chronic liver failure (ACLF) is a sudden deterioration of the liver function in a patient with liver cirrhosis accompanied by failure of one or more organ systems. This liver disease has a serious prognosis and the four-week mortality rate is 20-30%. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 1, 2016 Category: Science Source Type: news

Cirrhosis Underrecognized in Hepatocellular Cancer PatientsCirrhosis Underrecognized in Hepatocellular Cancer Patients
Are clinicians properly screening their patients with cirrhosis for hepatocellular carcinoma, and how important is timely identification of disease? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 1, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Simeprevir-Sofosbuvir for Chronic Hepatitis C With CirrhosisSimeprevir-Sofosbuvir for Chronic Hepatitis C With Cirrhosis
The combination of simeprevir (SMV) and sofosbuvir (SOF) is effective treatment for patients with chronic hepatitis C virus (HCV) genotype 1 infection and cirrhosis, according to results from OPTIMIST-2. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 25, 2016 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news

Antibiotics Side Effects on the Mitochondria
Science is just beginning to understand how important your mitochondria are to warding off the diseases of aging. And, as usual, mainstream medicine is lagging way behind. Along with your telomeres, the cellular time keepers at the ends of your chromosomes, your mitochondria are another key component of the anti-aging equation. You see, these tiny organelles in your cells are the power plants that turn fuel into energy for your body. Healthy mitochondria keep you young and energetic.  Research shows that damaged mitochondria can lead to: Schizophrenia and bipolar disorder; Alzheimer’s and Parkinson’s d...
Source: Al Sears, MD Natural Remedies - March 25, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures Source Type: news

Coffee Consumption and the Risk of CirrhosisCoffee Consumption and the Risk of Cirrhosis
Are coffee drinkers at an increased risk of cirrhosis or does the opposite hold true? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

5 Steps to Deal With a Chronic Illness
I was diagnosed with chronic hepatitis C in 1985, when it was still called non-A non-B. My doctor didn't sugar coat his words when he said to me: "Toni, I am sorry but there is no cure. You have a ticking time bomb inside and nobody can predict how long you have to live." My heart stopped and the course of my life was forever altered. For the next few years, I desperately tried every alternative medicine treatments and modalities to no avail. This virus is a formidable foe. It replicates itself at the speed of light and attacks healthy liver cells leading to fibrosis, cirrhosis and liver cancer. It is the leadin...
Source: Healthy Living - The Huffington Post - March 23, 2016 Category: Consumer Health News Source Type: news

Palliative Care for CirrhosisPalliative Care for Cirrhosis
How can clinicians best manage the end-of-life care needs of their patients with cirrhosis? Frontline Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Mitochondrial Function: The Other Half Of The Anti-Aging Story
Telomere science changed everything we knew about aging. But today, I want to talk to you about the other half of the anti-aging equation. Regular readers will already know by protecting your telomeres, you can slow — and even reverse — the aging process. You see, your telomeres are like little countdown clocks that protect the DNA in your cells. They shorten with each cell division. And the shorter they get the faster you develop the signs of aging. So by protecting and nourishing them, you can literally turn back the years. I was one of the first doctors to put telomere science to the test. And for years, I&...
Source: Al Sears, MD Natural Remedies - March 9, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging mitochondria telomere Source Type: news

Modified protein reverses cirrhosis in lab rats
A protein modified to increase the amount of time it circulates in the bloodstream appears to reverse liver fibrosis and cirrhosis in rats, according to results of a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 3, 2016 Category: Science Source Type: news

Study shows broccoli may offer protection against liver cancer
(University of Illinois College of Agricultural, Consumer and Environmental Sciences) Research has shown that eating broccoli three to five times per week can lower the risk of many types of cancers. Consuming a high-fat, high-sugar diet and having excess body fat is linked with the development of nonalcoholic fatty liver disease (NAFLD), which can lead to diseases such as cirrhosis and liver cancer. A new study from the University of Illinois shows that including broccoli in the diet may protect against liver cancer, as well as aid in countering the development of NAFLD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 3, 2016 Category: Global & Universal Source Type: news

Visceral Fat Triggers Heart Disease
I tell my patients to avoid drinking soda not just because they make you fat. Each sip of soda affects your health. Soda puts you at risk for health problems like metabolic syndrome. This is a collection of symptoms that can lead to diabetes, heart disease and other chronic diseases, like cancer. Soft drinks are the beverage of choice for millions of Americans. The latest research now reveals that sodas are a major cause of visceral fat — the deadliest kind of fat you can have, inflaming your tissues, rotting your blood vessels and upsetting your body chemistry. In a minute I’m going to tell you about a great ...
Source: Al Sears, MD Natural Remedies - February 29, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Heart Health heart disease metabolic syndrome Visceral Fat Source Type: news

Science proves these seven herbs provide powerful protection against liver cancer and liver damage of all kinds
(NaturalNews) More than 10 percent of the world's population currently suffers from some form of liver disease, whether it be fibrosis, cirrhosis, a hepatocellular carcinoma, alcoholic steatosis, or chronic hepatitis. And a great number of these folks use some kind of natural remedy... (Source: NaturalNews.com)
Source: NaturalNews.com - February 29, 2016 Category: Consumer Health News Source Type: news